SRI-AS1: A Potential Drug Target and Biomarker (G102723885)

Target Name: SRI-AS1

NCBI ID: G102723885

SRI-AS1

Other Name(s): SRI antisense RNA 1

SRI-AS1: A Potential Drug Target and Biomarker

SRI-AS1 (SRI antisense RNA 1) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer. Its unique structure and biochemical properties make it an attractive candidate for further research and development.

SRI-AS1 was first identified using transcriptome sequencing (RNA sequencing) technology. It was found to have a highly conserved sequence in the seed antigen gene family, which is a family of proteins that are involved in the development and maintenance of plant organelles. SRI-AS1 was also found to have a unique 5' end, which is not typical for a non-coding RNA molecule.

The biochemical properties of SRI-AS1 are also unique. It is a single molecule that is composed of a hairpin loop and a stem-loop, which are structural elements commonly found in RNA secondary structures. The stem-loop is a type of RNA structure that is composed of a central stem and two loops that extend from either side of the stem. The hairpin loop is a type of RNA structure that is composed of a stem and a loop that meets at the top, which is commonly found in RNA secondary structures.

SRI-AS1 has been shown to play a role in various biological processes, including cell growth, development, and disease. For example, SRI-AS1 has been shown to be involved in the regulation of cell cycle progression in cancer cells. It has also been shown to play a role in the development and progression of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

SRI-AS1 has also been shown to be a potential biomarker for various diseases, including cancer. Its unique structure and biochemical properties make it an attractive candidate for use as a diagnostic or therapeutic agent. For example, SRI-AS1 has been shown to be downregulated in various types of cancer, which suggests that it may be a potential target for cancer therapies.

In addition to its potential drug-target and biomarker properties, SRI-AS1 also has potential as a research tool. Its unique structure and biochemical properties make it an attractive candidate for use in RNA sequencing and other molecular biology techniques. For example, its hairpin loop and stem-loop structures could be used to study the structure and function of RNA molecules, including their regulation by post-transcriptional modifications.

Overall, SRI-AS1 is a unique and promising molecule that has the potential to be a drug target and biomarker for various diseases. Further research is needed to fully understand its properties and determine its potential uses in medicine.

Protein Name: SRI Antisense RNA 1

The "SRI-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SRI-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets